This is the authors' abstract. We don't add key points for this paper.
Catechol O-methyl transferase belongs to the diverse family of S-adenosyl-l-methionine transferases. It is a target involved in the treatment of Parkinson's disease. Here we present a fragment-based screening approach to discover noncatechol derived COMT inhibitors which bind at the SAM binding pocket. We describe the identification and characterization of a series of highly ligand efficient SAM competitive bisaryl fragments (LE = 0.33-0.58). We also present the first SAM-competitive small-molecule COMT co-complex crystal structure.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lanier et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: